BIOMAT Database Logo BIOMAT Database Logo

Half-life and in-vivo recovery of heated factor VIII concentrates. 1986

M Morfini, and A Messori, and G Longo, and S Cinotti, and M Matucci, and P Rossi Ferrini

UI MeSH Term Description Entries
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Morfini, and A Messori, and G Longo, and S Cinotti, and M Matucci, and P Rossi Ferrini
Calculations of factor VIII in vivo recovery and half-life.
January 1984, Scandinavian journal of haematology. Supplementum,
M Morfini, and A Messori, and G Longo, and S Cinotti, and M Matucci, and P Rossi Ferrini
Heat inactivation of extended half-life factor VIII concentrates.
March 2019, Haemophilia : the official journal of the World Federation of Hemophilia,
M Morfini, and A Messori, and G Longo, and S Cinotti, and M Matucci, and P Rossi Ferrini
Factor VIII degradation products in heated concentrates.
June 1986, Lancet (London, England),
M Morfini, and A Messori, and G Longo, and S Cinotti, and M Matucci, and P Rossi Ferrini
In vivo recovery and early half-life of infused factor VIII in haemophilia A.
January 1995, Haemophilia : the official journal of the World Federation of Hemophilia,
M Morfini, and A Messori, and G Longo, and S Cinotti, and M Matucci, and P Rossi Ferrini
Potency and in vivo recovery of high purity factor VIII concentrates.
July 1994, Thrombosis and haemostasis,
M Morfini, and A Messori, and G Longo, and S Cinotti, and M Matucci, and P Rossi Ferrini
In vivo recovery and survival of monoclonal-antibody-purified factor VIII concentrates.
December 1991, Thrombosis and haemostasis,
M Morfini, and A Messori, and G Longo, and S Cinotti, and M Matucci, and P Rossi Ferrini
Clinical study of recovery and half-life of vapor-heated factor VII concentrate.
January 1994, Transfusion,
M Morfini, and A Messori, and G Longo, and S Cinotti, and M Matucci, and P Rossi Ferrini
An in vivo assessment of factor VIII concentrates.
August 1985, JAMA,
M Morfini, and A Messori, and G Longo, and S Cinotti, and M Matucci, and P Rossi Ferrini
Extended half-life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products.
February 2021, Research and practice in thrombosis and haemostasis,
M Morfini, and A Messori, and G Longo, and S Cinotti, and M Matucci, and P Rossi Ferrini
von Willebrand factor contributes to longer half-life of PEGylated factor VIII in vivo.
July 2013, Haemophilia : the official journal of the World Federation of Hemophilia,
Copied contents to your clipboard!